Tuesday, November 10, 2026

@aleabitoreddit Oct 27 3 clicks

Serenity on X

I made a new “It’s All Over” portfolio today of even higher beta names than $AAOI. The requirements: 1. Fell off a cliff 2. Lower than when they announced their catalysts 3. Increasing fundamentals 4. Looks like the chart 5. Short interest spiking Stuff like $ALMU at $7, $CIFR at $8, $ASTS at $39, and some Leopold trades like $TE at $2.5, $SHAZ at $25. Not a recommendation, just curious how this performs into year end while doomposts are everywhere. Anyone got any other ones?

@TheBenSchmark Oct 27

JabroniCoin.USD on X

David Einhorn: We think $CENX will beat consensus estimates, as the sell-side is not yet capturing all the subsidy and tariff benefits … expect to generate cash equal to 90% of EV by the end of the Trump administration But there’s more…

@stockgutter Oct 27 1 click

SG on X

Buying $KYIV here. Cheap optionality on a deal imo, and if no deal it should be fine too.

@StableBread Oct 27 1 click

Fajasy on X

The IPO price, share count, and run-rate revenue as of October 31, 2026 are still blank, and so is how much cash Anthropic will spend on employees' taxes for RSUs that settle at the IPO. Anthropic plans to list on Nasdaq as $ANT, with $GS and $MS leading the deal. Five of Anthropic's co-founders are also selling shares in the IPO, although the S-1 leaves the number blank. Anthropic's lock-ups release shares in stages, with 23 scheduled release dates over its first year as a public company, starting on its first trading day. So instead of one lock-up expiration, insider shares can hit the market every few weeks for a year. Read the S-1 yourself on SECSift: Read the S-1 yourself on SECSift:

@StableBread Oct 27

Fajasy on X

Anthropic also had three run-ins with the U.S. government in 2026: 1) On February 27, the President ordered federal agencies to stop using Anthropic's models, and the Department of War designated the company a supply-chain risk to national security. Anthropic largely won its district court case, but lost a separate 2-1 ruling at the D.C. Circuit on September 25, 2026, and has asked the full court to rehear the case. 2) In June, Anthropic disabled its Fable 5 and Mythos 5 models for all customers when the Commerce Department restricted their export worldwide (since lifted). 3) In October, the FTC sent Anthropic a civil investigative demand (a formal request for information) on its consumer protection, data protection, and privacy practices, and the safety and security of its products. Anthropic also still owed $1.2B of its $1.5B Bartz settlement with book authors as of June 30, 2026, and faces training-data suits from music publishers, Canadian authors and news publishers, and Reddit $RDDT.

@junkbondinvest Oct 27 2 clicks

junkbondinvestor on X

Bending Spoons new issue: Sr Sec $1bn 5NC2 Rating: Ba3/BB- IPT: low 10s The company has a ~$30bn market cap...👀 $BSP

@calvinblissett Oct 27

Calvin Blissett on X

I'm sorry it's a pretty bold claim "a better $NVR" I should elaborate. Cury looks like NVR transplanted into a structurally tighter housing market, with even stronger current unit economics. On an apples-to-apples S&P Global methodology, Cury generated 84.2% ROIC in 2025 versus 47.0% for NVR, while Cury's inventory turned 3.77x versus NVR's 3.26x.. ROIC is preferable here to ROE or EPS because NVR's enormous buybacks reduce shares and equity and can make per-share growth and ROE look better. The opportunity set is also more extreme: Brazil's official housing deficit is 5.77 million homes, equal to 7.4% of occupied households, while Freddie Mac estimates the U.S. shortage at 3.7 million units against roughly 150.8 million housing units, or ~2.5% of housing stock. FJP Cury then concentrates affordable housing in São Paulo and Rio, precisely where affordability and housing scarcity are most acute because these are the richest cities in Brazil, while using land swaps, customer presales and subsidized MCMV financing to keep remarkably little of its own capital trapped in each project. The result is basically the feature that makes NVR exceptional pushed further: Cury currently turns each real of invested capital substantially harder, while operating against a relative housing shortage several times larger than America's.

@StableBread Oct 27 1 click

Fajasy on X

My bear, base, and bull cases value Boost Run’s $BRUN stock on year-end 2026 ARR (on the same basis as the multiples of CoreWeave $CRWV, Nebius $NBIS, and $IREN), which $BRUN will report with its Q4 results in March 2027. None of the three cases adds the $160.7M/year from the July order and Cohere, since both start in 2027. The peers’ contracts that start after 2026 aren’t in their year-end ARR either, so they’re priced into the multiples instead. Since the peers’ multiples leave out the debt they’ll take on to reach year-end ARR, I hold $BRUN’s net debt at today’s $244.3M, rather than adding the lease debt from its H2 2026 build. Each case’s value is year-end ARR times the multiple, minus the $244.3M of net debt, divided by the 88.8M fully diluted shares plus any new shares from a stock sale. I start with the $231.4M of ARR from contracts already running, then add (1) the June order’s $69.2M/year if it starts by December 31 and (2) however much of the $99.4M from contracts without disclosed terms is running by then. Bear case ($4.76, -46%) The bear case assumes $BRUN has no new financing to show by its Q3 report, lessors fund 70% of the H2 2026 build instead of 79.5% (below the 72.0% lessors funded in 2025), and the June order’s November 30 start slips into 2027, so 2026 GPU spending stays at the $1.0B low end of management’s range. That implies year-end ARR of $280M, 30% short of the target, a $62.2M stock sale at $8.89/share (7.0M new shares) to cover the funding gap and three months of 2027 payments, and today’s 2.5x, for a value of $4.76/share. I give the bear case about a 20% chance. Base case ($16.17, +82%) The base case assumes $BRUN lands new lease or asset-backed financing by year-end, starts the June order on November 30, and reaches its $400M target without selling stock. That implies $400M of year-end ARR at CoreWeave’s 4.2x, the median of the three peers, for a value of $16.17/share. I use today’s median, since the base case only solves $BRUN’s own financing problem. It assumes no relief on rates or borrowing costs, which would lift the peers’ multiples too. Bull case ($19.78, +122%) The bull case assumes everything in the base case, plus relief on rates and borrowing costs that lifts the peers’ multiples. That implies $400M of year-end ARR at 5.0x, still below Nebius’s 5.9x, for a value of $19.78/share. So the bull case is really a bet on the market, not on anything more from $BRUN. From $8.89/share, you’re risking a $4.13 loss (-46%) in the unlikely bear case for a $10.89 gain (+122%) in the more likely bull case. P.S. These cases use the October 16 close and predate $BRUN’s October 26 release, which says it has closed more than $600M of non-dilutive project financing in 2026.